array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Natus Medical Incorporated"
["slug"]=>
string(35) "05e48-us-natus-medical-incorporated"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/a15c3f67-a529-4950-a831-d87d6d0fff2a"
["description"]=>
string(897) "Natus Medical Incorporated (Natus) offers medical equipment, software, supplies and services for the diagnosis, monitoring, and treatment of impairments and disorders effecting the brain, neural pathways, and eight sensory nervous systems.
Our comprehensive product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. Our products are trusted by medical professionals in university medical centers, hospitals, private practices, clinics and research laboratories around the world.
Natus does not endorse personal/non-work related comments made by employees on social media. Further, Natus values the respect and inclusion of all people without regard to race, color, religion, sex, national origin, veteran status, disability, sexual orientation, gender identity, or any other protected status."
["address_street"]=>
string(29) "6701 Koll Center Pkwy Ste 120"
["address_place"]=>
string(10) "Pleasanton"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1987-02-13"
["website_domain"]=>
string(9) "natus.com"
["website_url"]=>
string(17) "https://natus.com"
["industry_codes"]=>
array(1) {
[0]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(1480)
["article_count"]=>
int(148)
}
["articles"]=>
array(3) {
[0]=>
array(7) {
["title_en"]=>
string(65) "Natus Medical (NASDAQ:NTUS) is currently covered by StockNews.com"
["snippet_en"]=>
string(193) "Stock analysts at StockNews.com started coverage on shares of Natus Medical (NASDAQ:NTUS – Get Rating) in a note issued to investors on Thursday. The firm set a “buy” rating on the stock."
["url"]=>
string(89) "https://reporter.am/2022/10/01/natus-medical-nasdaqntus-now-covered-by-stocknews-com.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/a12680e7-4586-4c98-8bf2-751ad0dcfc81"
["source"]=>
string(11) "reporter.am"
["publication_date"]=>
string(10) "2022-10-01"
["categories"]=>
array(4) {
[0]=>
string(14) "Issuing Shares"
[1]=>
string(10) "Litigation"
[2]=>
string(12) "Stock Market"
[3]=>
string(13) "Credit Rating"
}
}
[1]=>
array(7) {
["title_en"]=>
string(75) "Natus Medical (NASDAQ:NTUS) Coverage Initiated by Analysts at StockNews.com"
["snippet_en"]=>
string(197) "StockNews.com initiated coverage on shares of Natus Medical (NASDAQ:NTUS – Get Rating) in a research report sent to investors on Wednesday morning. The brokerage issued a buy rating on the stock."
["url"]=>
string(108) "https://reporter.am/2022/09/22/natus-medical-nasdaqntus-coverage-initiated-by-analysts-at-stocknews-com.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e16b7f9f-79b4-4046-b1c1-05aea17b9efb"
["source"]=>
string(11) "reporter.am"
["publication_date"]=>
string(10) "2022-09-22"
["categories"]=>
array(4) {
[0]=>
string(14) "Issuing Shares"
[1]=>
string(10) "Litigation"
[2]=>
string(12) "Stock Market"
[3]=>
string(13) "Credit Rating"
}
}
[2]=>
array(7) {
["title_en"]=>
string(47) "Natus Medical Stock Hits New 52-Week Low (BABY)"
["snippet_en"]=>
string(242) "Natus Medical (Nasdaq:BABY) hit a new 52-week low Monday as it is currently trading at $9.03, below its previous 52-week low of $9.05 with 154,093 shares traded as of 2:30 p.m. ET. Average volume has been 347,600 shares over the past 30 days."
["url"]=>
string(88) "https://www.thestreet.com/markets/natus-medical-stock-hits-new-52-week-low-baby-11266055"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/f0336af5-fcc4-4ba3-b6c2-d6588f7897dd"
["source"]=>
string(13) "thestreet.com"
["publication_date"]=>
string(10) "2011-10-03"
["categories"]=>
array(3) {
[0]=>
string(24) "Stock Research & Ratings"
[1]=>
string(12) "Stock Market"
[2]=>
string(14) "Issuing Shares"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(23)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(12)
}
[2]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(11)
}
[3]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(7)
}
[4]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(7)
}
[5]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(5)
}
[6]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(4)
}
[7]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(4)
}
[8]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(4)
}
[9]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(3)
}
[10]=>
array(2) {
["name"]=>
string(5) "SPACs"
["count"]=>
int(3)
}
[11]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(3)
}
[12]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(3)
}
[13]=>
array(2) {
["name"]=>
string(10) "Executives"
["count"]=>
int(3)
}
[14]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(2)
}
[15]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(2)
}
[16]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(2)
}
[17]=>
array(2) {
["name"]=>
string(10) "Downsizing"
["count"]=>
int(2)
}
[18]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(2)
}
[19]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(2)
}
[20]=>
array(2) {
["name"]=>
string(11) "Name Change"
["count"]=>
int(2)
}
[21]=>
array(2) {
["name"]=>
string(22) "Shareholder Reputation"
["count"]=>
int(2)
}
[22]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(2)
}
[23]=>
array(2) {
["name"]=>
string(5) "Fraud"
["count"]=>
int(1)
}
[24]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(1)
}
[25]=>
array(2) {
["name"]=>
string(19) "Investment Requests"
["count"]=>
int(1)
}
[26]=>
array(2) {
["name"]=>
string(5) "Debts"
["count"]=>
int(1)
}
[27]=>
array(2) {
["name"]=>
string(25) "Leadership and Governance"
["count"]=>
int(1)
}
[28]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(1)
}
[29]=>
array(2) {
["name"]=>
string(10) "Complaints"
["count"]=>
int(1)
}
}
}
05e48-us-natus-medical-incorporated
Natus Medical Incorporated
Location
California
Founded
1987-02-13
Website
https://natus.com
Articles
148 Articles
Category
Electromedical and Electrotherapeutic Apparatus
Description
Natus Medical Incorporated (Natus) offers medical equipment, software, supplies and services for the diagnosis, monitoring, and treatment of impairments and disorders effecting the brain, neural pathways, and eight sensory nervous systems.
Our comprehensive product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. Our products are trusted by medical professionals in university medical centers, hospitals, private practices, clinics and research laboratories around the world.
Natus does not endorse personal/non-work related comments made by employees on social media. Further, Natus values the respect and inclusion of all people without regard to race, color, religion, sex, national origin, veteran status, disability, sexual orientation, gender identity, or any other protected status.
Stock analysts at StockNews.com started coverage on shares of Natus Medical (NASDAQ:NTUS – Get Rating) in a note issued to investors on Thursday. The firm set a “buy” rating on the stock.
StockNews.com initiated coverage on shares of Natus Medical (NASDAQ:NTUS – Get Rating) in a research report sent to investors on Wednesday morning. The brokerage issued a buy rating on the stock.
Natus Medical (Nasdaq:BABY) hit a new 52-week low Monday as it is currently trading at $9.03, below its previous 52-week low of $9.05 with 154,093 shares traded as of 2:30 p.m. ET. Average volume has been 347,600 shares over the past 30 days.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
